Is topical roflumilast set to become a dermatological panacea?
Hospital Pharmacy Europe
JUNE 19, 2023
Topical roflumilast is being increasingly trialled for a number of skin conditions but how effective is it, and will it take centre stage in the field of dermatology? Oral roflumilast is licensed for maintenance treatment in severe chronic obstructive pulmonary disease. Psoriasis management Topical roflumilast 0.3%
Let's personalize your content